Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression via targeting EGFR

Our results demonstrate that caffeine stimulates the EGFR-ERK1/2 pathway to increase the LDLR expression and ameliorate nonalcoholic fatty liver disease (NAFLD) in HFD-fed ApoE KO mice.